Across the United States, overdose death rates declined between 2023 and 2024, but some demographics did not follow this trend.

CNS stimulants vs nonstimulants may yield better clinical outcomes for adolescents and young adults with ADHD and comorbid depression.

Tris Pharma launches a new, compact 60mL bottle size for Dyanavel XR (amphetamine) oral suspension for ADHD, improving pharmacy stocking and patient access.

Pediatric patients with neurodevelopmental disorders experience a substantially increased risk for co-occurring psychiatric conditions.

A new set of billing codes will change how people pay for services related to pregnancy, childbirth, and postpartum care.

Temporal patterns in US pediatric mental health care reveal persistent racial and ethnic disparities in treatment incidence rates.

People in the US are generally in favor of increased regulatory action focused on improving diet and food accessibility.

Legislators propose a bipartisan bill to establish a federal Office of Men's Health within the Department of Health and Human Services.

Metabolic dysfunction is not associated with increased mortality among individuals with severe alcohol-associated hepatitis.

Basivertebral nerve ablation provided meaningful pain improvement for patients with vertebrogenic chronic low back pain.

Adding eptinezumab to patient education significantly reduces headache burden and work impairment in adults with chronic migraine.

Closer residential proximity to lead-releasing facilities corresponds to poorer episodic memory in older adults.